These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10784424)

  • 1. Pharmacokinetics of diethylcarbamazine: prediction by concentration in saliva.
    Ilondu N; Orisakwe OE; Ofoefule S; Afonne OJ; Obi E; Chilaka KC; Orish C
    Biol Pharm Bull; 2000 Apr; 23(4):443-5. PubMed ID: 10784424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some plasma and saliva pharmacokinetics parameters of rifampicin in the presence of pefloxacin.
    Orisakwe OE; Akunyili DN; Agbasi PU; Ezejiofor NA
    Am J Ther; 2004; 11(4):283-7. PubMed ID: 15266220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of plasma and saliva concentrations of lamotrigine in healthy volunteers.
    Incecayir T; Agabeyoglu I; Gucuyener K
    Arzneimittelforschung; 2007; 57(8):517-21. PubMed ID: 17915637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of diethylcarbamazine after single oral dose at two different times of day in human subjects.
    Bolla S; Boinpally RR; Poondru S; Devaraj R; Jasti BR
    J Clin Pharmacol; 2002 Mar; 42(3):327-31. PubMed ID: 11865970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceleration of body clearance of diethylCarbamazine by oral activated charcoal.
    Orisakwe OE; Ilondu NA; Afonne OJ; Ofoefule SI; Orish CN
    Pharmacol Res; 2000 Aug; 42(2):167-70. PubMed ID: 10887047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of pemoline in plasma, saliva and urine following oral administration.
    Vermeulen NP; Teunissen MW; Breimer DD
    Br J Clin Pharmacol; 1979 Nov; 8(5):459-63. PubMed ID: 508551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability, pharmacokinetics, and bioequivalence of the tablet and syrup formulations of lacosamide in plasma, saliva, and urine: saliva as a surrogate of pharmacokinetics in the central compartment.
    Cawello W; Bökens H; Nickel B; Andreas JO; Halabi A
    Epilepsia; 2013 Jan; 54(1):81-8. PubMed ID: 23148731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot study of the disposition of pilocarpine in plasma, saliva and urine after a single oral dose.
    Aromdee C; Ferguson MM; Ledger R; Wall J
    Eur J Pharm Sci; 1999 May; 8(2):81-3. PubMed ID: 10210729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of omeprazole on the pharmacokinetics of metronidazole and hydroxymetronidazole in human plasma, saliva and gastric juice.
    Jessa MJ; Goddard AF; Barrett DA; Shaw PN; Spiller RC
    Br J Clin Pharmacol; 1997 Sep; 44(3):245-53. PubMed ID: 9296318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of renal disease on the pharmacokinetics of diethylcarbamazine in man.
    Adjepon-Yamoah KK; Edwards G; Breckenridge AM; Orme ML; Ward SA
    Br J Clin Pharmacol; 1982 Jun; 13(6):829-34. PubMed ID: 7093114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental filariasis of Dipetalonema dessetae in Proechimys oris: 3. Effects of parasitism on the pharmacokinetics of diethylcarbamazine.
    Kani F; Gayral P; Pfaff-Dessales MC; Mahuzier G; Jacquot C; Auget JL
    Eur J Drug Metab Pharmacokinet; 1983; 8(4):313-20. PubMed ID: 6687054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of pharmacokinetic parameters of digoxin from serum, saliva and urine.
    Allonen H; Iisalo E; Kangas L; Lammintausta R; Salonen M
    Int J Clin Pharmacol Biopharm; 1978 Sep; 16(9):420-3. PubMed ID: 700915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between plasma and saliva quinine levels in humans.
    Babalola CP; Bolaji OO; Ogunbona FA; Dixon PA
    Ther Drug Monit; 1996 Feb; 18(1):30-3. PubMed ID: 8848817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once-daily atazanavir/cobicistat and darunavir/cobicistat exposure over 72 h post-dose in plasma, urine and saliva: contribution to drug pharmacokinetic knowledge.
    Elliot ER; Amara A; Pagani N; Else L; Moyle G; Schoolmeesters A; Higgs C; Khoo S; Boffito M
    J Antimicrob Chemother; 2017 Jul; 72(7):2035-2041. PubMed ID: 28407075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers.
    Jufer RA; Wstadik A; Walsh SL; Levine BS; Cone EJ
    J Anal Toxicol; 2000 Oct; 24(7):467-77. PubMed ID: 11043648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saliva vs. plasma bioequivalence of paracetamol in humans: validation of class I drugs of the salivary excretion classification system.
    Idkaidek N; Arafat T
    Drug Res (Stuttg); 2014 Oct; 64(10):559-62. PubMed ID: 24452519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of metronidazole in saliva.
    Mustofa ; Suryawati S; Santoso B
    Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):474-8. PubMed ID: 1813432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excretion of proguanil in human saliva.
    Onyeji CO; Ogunbona FA; Dixon PA
    J Pharm Pharmacol; 1989 Dec; 41(12):872-3. PubMed ID: 2576454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose related pharmacokinetics of ofloxacin in healthy volunteers.
    Immanuel C; Hemanthkumar AK; Gurumurthy P; Venkatesan P
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):1017-22. PubMed ID: 12475149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of two erythromycin esters in plasma and in saliva following oral administration in humans.
    Ducci M; Scalori V; del Tacca M; Soldani G; Bernardini C; Grothe E; Bertelli A
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):494-7. PubMed ID: 7298242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.